Researchers: Tiotropium inhaler may raise mortality risk - Related Stories - ANA SmartBrief
Links shared publicly online about this topic.
- 217total visits
Researchers: Tiotropium inhaler may raise mortality risk - Related Stories - ANA SmartBrief
People who used a Spiriva Respimat inhaler to ease breathing problems linked to lung diseases such as chronic bronchitis and emphysema were 52% more likely to die compared with a placebo group, a 6,500-participant study published in the British Medical Journal found. Researchers estimated that ther…
View full resource at smartbrief.com
Tags: Lung, Breathing, COPD Medication, Disease and Condition, Spiriva, Mortality, disease
Most Recently Shared on June 15, 2011 at 5:05 pm By:
Researchers: Tiotropium inhaler may raise mortality risk http://t.co/kGAN9J5 #fb
Also Shared By:
Advertisement
Carole Eldridge, DNP
@Nerdnurse
Researchers: Tiotropium inhaler may raise mortality risk http://t.co/y0p4yNL
1 year ago...